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Results: There were 221 patients who had 225 percutaneous filter retrieval attempts. Four patients had two attempts. Technical success in percutaneous retrieval of the filter was 200 of 225 (89%) at a mean of 6 6 4 months from implantation. Of the 21 patients whose filters could not be percutaneously retrieved, all but one had significant filter barb penetration through the caval wall with tilting. Most (19 of 21 [ 90%] ) were asymptomatic, and none had further complications during a mean follow-up of 3.9 years (range, 9-66 months). The two patients with abdominal pain whose filters could not be retrieved percutaneously underwent open surgical removal through minilaparotomy. An additional five patients for whom percutaneous retrieval failed at other institutions were referred to us for open surgical removal because of symptoms or complications. Technical success for all open surgical removal of IVC filters was 100%. There were no perioperative deaths or significant morbidities. All patients had resolution of their symptoms after percutaneous or open surgical removal.
Conclusions: Asymptomatic patients with unsuccessful percutaneous IVC filter retrieval appear to have low complications in midterm follow-up despite significant filter strut penetration through the caval wall into adjacent structures. Without symptoms or other complications, such patients do not require referral for open surgical filter removal. Symptomatic patients can expect low morbidity and resolution of symptoms after percutaneous or open surgical removal. Further studies are needed to determine the cost-effectiveness of routine removal of asymptomatic IVC filters. Methods: We identified C3 patients in our EVA database treated from January 21 to March 19, 2015, and surveyed the amount of edema (currently and immediately after the procedure), the use of compression stockings, and the current satisfaction with the procedure. The Venous Severity Disease Score (VSDS) was calculated, and statistical analysis evaluated risk factors for edema resolution (ER), compression stocking benefit (CSB), and patient satisfaction (PS).
Results: There were 1634 limbs treated by EVA with or without adjunctive segmental varicose vein microphlebectomy, with 528 limbs being C3; 92 patients (Table I) accounting for 130 ablations in 128 limbs with a VSDS average of 2.7 (range, 1-5.5) responded to the survey (Table II) . At the time of the survey, 97 limbs (75.8%) had reduced or resolved swelling, 29 limbs (22.6%) were unchanged, and 2 limbs (1.6%) had increased swelling. Multivariate analysis of age, gender, body mass index (BMI), diuretic use (DU), microphlebectomy, and VSDS revealed that VSDS and DU were associated with an increased amount of preoperative edema (P < .01) and patients having microphlebectomy had less preoperative edema. Microphlebectomy was the only predictive factor for ER (immediate [P ¼ .02] and delayed [P ¼ .01]). Higher VSDS (P ¼ .01) and DU (P ¼ .03) had negative impact on CSB. Microphlebectomy predicted high PS with ER (P ¼ .01). Age, gender, and BMI had no effect on ER, CSB, or PS.
Conclusions: Venous ablation for edema secondary to superficial venous insufficiency is effective and durable with high PS. Microphlebectomy during EVA improves ER and PS. Higher VSDS is predictive of increased preoperative edema but not of ER or PS. Age, gender, and Objective: A D-dimer (DD) level in addition to the pretest clinical probability (PCP) score using Wells criteria can safely exclude deep venous thrombosis (DVT). In the current study, we sought to examine the correlation between the proposed DD level and the PCP model in approaching diagnosis and to determine the location and severity of a possible DVT in high-volume hospitals.
Methods: Patients who presented with limb swelling with or without pain were retrospectively examined from June 2014 to July 2015. After calculation of PCP, patients were divided into low, moderate, and high risk. Electronic DD results using enzyme-linked immunosorbent assay, PCP data, and venous duplex ultrasound (VDU) analysis data were merged and analyzed on the basis of receiver operating characteristic curve to determine the DD cutoff point for each PCP score (Fig) . An abnormal DD level with an average value of $0.6 mg/L was correlated to positive DVT to differentiate proximal (above popliteal vein) from distal (below popliteal vein).
Results: Data of 1909 patients were analyzed, and 239 (12.5%) were excluded secondary to previous history of DVT. Average age was 62.1 6 16.3 years, and 55.7% were female; the majority presented with limb pain and edema (87%). DD analysis was completed in 202 patients and correlated with all positive and negative DVT results (100% sensitivity and positive predictive value). In 26 of 202, DD levels were in the normal range (0.1-0.59 mg/L), all of which were negative for DVT (100% sensitive); in 51 of 202 with DD values in the range of 0.6 to 1.2 mg/L, only 3 DVTs were recorded, all of them distal. Also, for 668 patients with PCP score <1, patients with positive DD results were sent for VDU examination. Thus, 745 patients had an un-needed VDU study, a potential charge savings for VDU for all (745 Â $1557 ¼ $1,159,965) and DD for all (745 Â $182 ¼ $135,595), with total potential savings of $1,024,370.
Conclusions: This study suggests that D-dimer is still underused and along with PCP can reduce a significant number of un-needed VDU examinations. Higher value of DD (>1.2 mg/L) may raise concern for proximal DVT. Concern on cost-effectiveness exists and raises the demand for the proposed algorithm to be followed. Objective: Thoracoabdominal aortic aneurysms (TAAAs) and aortic dissection (AD) often involve the infrarenal aorta. We review our experience with infrarenal aortic repair as part of a hybrid strategy to treat complex aortic disease.
Methods: A prospectively maintained database of patients undergoing intervention for TAAA or AD was reviewed. Diagnosis, imaging features, nature of the infrarenal repair (one vs two stage), endoleak, need for additional interventions, morbidity, and mortality were collected.
Results: Between 2006 and 2016, there were 21 patients with TAAA who underwent open infrarenal aortic repair or replacement combined with endovascular repair in a single multiple-stage procedure. Fourteen patients also had AD. In 36% of the patients with AD, the infrarenal replacement surgical graft created a distal seal zone, allowing false lumen intentional placement of an endograft to treat the proximal AD. In one of these patients, the true lumen continued to perfuse intercostal arteries, and in another, intercostal arteries originating in the false lumen distal to the end of the endograft were preserved. Fourteen cases were completed in two or more stages. Three patients had infrarenal aortic replacement with debranching only. Operative mortality was 4.8% (Table) . Patients were observed from 3 months to 7 years. Three patients have stable type II endoleaks and one patient required subsequent replacement of ascending aortic arch for aneurysmal disease. Two patients died of unrelated cause.
Conclusions: Infrarenal aortic repair for treatment of TAAA and AD can be performed with low morbidity and mortality and excellent mediumterm results. In patients with AD, this strategy can resolve malperfusion while simultaneously creating a landing zone using the false lumen as the conduit for the stent graft (false lumen intentional placement), which allows full expansion of the endograft, potential preservation of lumbar/ intercostal artery flow, and exclusion of the weaker false lumen. Patient required laparotomy and renal graft thrombectomy; pancreatic fistula resolved. e Patient succumbed to the rupture of his TAAA (8 cm in maximum diameter) on postoperative day 4 before the planned second stage of the procedure could be performed.
